Prati
Giovanni Bocci
Giovanni Bocci
Post Doc Fellow, University of New Mexico School of Medicine
Potvrđena adresa e-pošte na salud.unm.edu
Naslov
Citirano
Citirano
Godina
How many rare diseases are there?
M Haendel, N Vasilevsky, D Unni, C Bologa, N Harris, H Rehm, ...
Nature Reviews Drug Discovery 19 (2), 77-78, 2020
1082020
DrugCentral 2021 supports drug discovery and repositioning
S Avram, CG Bologa, J Holmes, G Bocci, TB Wilson, DT Nguyen, ...
Nucleic acids research 49 (D1), D1160-D1169, 2021
692021
TCRD and Pharos 2021: mining the human proteome for disease biology
TK Sheils, SL Mathias, KJ Kelleher, VB Siramshetty, DT Nguyen, ...
Nucleic acids research 49 (D1), D1334-D1346, 2021
462021
ADME-Space: a new tool for medicinal chemists to explore ADME properties
G Bocci, E Carosati, P Vayer, A Arrault, S Lozano, G Cruciani
Scientific reports 7 (1), 1-13, 2017
412017
Virtual and In Vitro Antiviral Screening Revive Therapeutic Drugs for COVID-19
G Bocci, SB Bradfute, C Ye, MJ Garcia, J Parvathareddy, W Reichard, ...
ACS pharmacology & translational science 3 (6), 1278-1292, 2020
282020
REDIAL-2020: A Suite of Machine Learning Models to Estimate Anti-SARS-CoV-2 Activities.
G Kc, G Bocci, S Verma, M Hassan, J Holmes, J Yang, S Sirimulla, ...
ChemRxiv: the preprint server for chemistry, 2020
26*2020
Side-chain modified ergosterol and stigmasterol derivatives as liver X receptor agonists
M Marinozzi, FF Castro Navas, D Maggioni, E Carosati, G Bocci, ...
Journal of Medicinal Chemistry 60 (15), 6548-6562, 2017
202017
How to illuminate the druggable genome using pharos
T Sheils, SL Mathias, VB Siramshetty, G Bocci, CG Bologa, JJ Yang, ...
Current protocols in bioinformatics 69 (1), e92, 2020
152020
Cyto-and enzyme toxicities of ionic liquids modelled on the basis of VolSurf+ descriptors and their principal properties
A Paternò, G Bocci, G Cruciani, CG Fortuna, L Goracci, S Scire, ...
SAR and QSAR in Environmental Research 27 (3), 221-244, 2016
152016
Modelling the aquatic toxicity of ionic liquids by means of VolSurf in silico descriptors
A Paternò, G Bocci, L Goracci, G Musumarra, S Scirè
SAR and QSAR in Environmental Research 27 (1), 1-15, 2016
132016
New insights in the in vitro characterisation and molecular modelling of the P-glycoprotein inhibitory promiscuity
G Bocci, A Moreau, P Vayer, C Denizot, O Fardel, Y Parmentier
European Journal of Pharmaceutical Sciences 121, 85-94, 2018
122018
Can BDDCS illuminate targets in drug design?
G Bocci, LZ Benet, TI Oprea
Drug discovery today 24 (12), 2299-2306, 2019
42019
State of the Art and Uses for the Biopharmaceutics Drug Disposition Classification System (BDDCS): New Additions, Revisions, and Citation References
G Bocci, TI Oprea, LZ Benet
The AAPS journal 24 (2), 1-17, 2022
22022
Combining machine learning and quantum mechanics yields more chemically aware molecular descriptors for medicinal chemistry applications
S Tortorella, E Carosati, G Sorbi, G Bocci, S Cross, G Cruciani, L Storchi
Journal of Computational Chemistry 42 (29), 2068-2078, 2021
22021
GLUT3 inhibitor discovery through in silico ligand screening and in vivo validation in eukaryotic expression systems
CV Iancu, G Bocci, M Ishtikhar, M Khamrai, M Oreb, TI Oprea, J Choe
Scientific reports 12 (1), 1-13, 2022
12022
Supervised learning with word embeddings derived from PubMed captures latent knowledge about protein kinases and cancer
V Ravanmehr, H Blau, L Cappelletti, T Fontana, L Carmody, B Coleman, ...
NAR genomics and bioinformatics 3 (4), lqab113, 2021
12021
Prediction of Ligand Activity at Subcellular Location
M Varshney, S Verma, G KC, G Bocci, TI Oprea, S Sirimulla
2021
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–17